Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432154 · ClinicalTrials.gov registry record · NA
An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis
A NA study, sponsored by Stratpharma.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05432154: Completed NA study, sponsored by Stratpharma.
NCT05432154 is a NA study that has completed, run by Stratpharma. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432154, a NA study, has completed, sponsored by Stratpharma.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients
Primary Outcome
Vulvar Quality of Life Index
Interventions
- DEVICE Film forming silicone gel (7-0940)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT05432154 record still lists
NCT05432154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Film forming silicone gel (7-0940) is the first listed.
NCT05432154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05432154 about?
NCT05432154 is a clinical study titled "An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis". The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients
What is the current status of trial NCT05432154?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-04-01. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT05432154?
The interventions under investigation include: Film forming silicone gel (7-0940) (DEVICE).
Who is sponsoring clinical trial NCT05432154?
This trial is sponsored by Stratpharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05432154's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI